Evidence map›Paper›PMID 35921107›Full record

ArticleJAMA network open2022

COVID-19 Vaccination Intentions, Concerns, and Facilitators Among US Parents of Children Ages 6 Months Through 4 Years.

Aaron M Scherer, Courtney A Gidengil, Amber M Gedlinske, Andrew M Parker, Natoshia M Askelson, Kate R Woodworth, Christine A Petersen, Megan C Lindley

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aaron M SchererDepartment of Internal Medicine, University of Iowa, Iowa City.
Courtney A GidengilRAND Corporation, Boston, Massachusetts.
Amber M GedlinskeDepartment of Internal Medicine, University of Iowa, Iowa City.
Andrew M ParkerRAND Corporation, Piitsburgh, Pennsylvania.
Natoshia M AskelsonDepartment of Community and Behavioral Health, University of Iowa, Iowa City.
Kate R WoodworthCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Christine A PetersenDepartment of Internal Medicine, University of Iowa, Iowa City.
Megan C LindleyCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
University of Iowa · USCenters for Disease Control and Prevention · USRAND Corporation · US

Funding

RFA-IP20-005: Informing Immunization Strategies Through Rapid, Repeated Computer-Assisted Self-Interviewing Instruments and Online Panels of Physicians and the PublicU01IP001144 · IP · UNIVERSITY OF IOWA · PI GIDENGIL, COURTNEY, PARKER, ANDREW · 2020 to 2024
$2.9M
Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older AdultsK01AG065440 · NIA · UNIVERSITY OF IOWA · PI SCHERER, AARON MICHAEL · 2020 to 2024
$611k
NCIRD CDC HHS U01 IP001144NIA NIH HHS K01 AG065440
6 · The paper itself

Abstract

Importance: Children aged 6 months through 4 years have become eligible for COVID-19 vaccination, but little is known about parental intentions regarding, concerns about, or facilitators to COVID-19 vaccination for this age group. Objectives: To evaluate parental intentions, concerns, and facilitators for COVID-19 vaccination for children aged 6 months through 4 years and to help inform the US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices' deliberations and recommendations for COVID-19 vaccination for children aged 6 months through 4 years. Design, Setting, and Participants: This cross-sectional study fielded an online survey from February 2 to 10, 2022, among a nonprobability sample of US parents of children aged 6 months through 4 years who were recruited through Qualtrics using quota-based sampling for respondent gender, race and ethnicity, and child age group. Main Outcomes and Measures: COVID-19 vaccination intentions, time to COVID-19 vaccination, COVID-19 vaccination concerns and facilitators, and trusted COVID-19 vaccination locations for children aged 6 months through 4 years. Results: The final weighted sample of 2031 participants (73.5% participation rate) had more respondents who identified as male (985; weighted percentage, 54.8%) or White (696; weighted percentage, 66.2%), were aged 25 to 49 years (1628; weighted percentage, 85.6%), had at least a bachelor's degree (711; weighted percentage, 40.0%), lived in a metropolitan area (1743; weighted percentage, 82.9%) or the South (961; weighted percentage, 43.4%), or received at least 1 dose of a COVID-19 vaccine (1205; weighted percentage, 59.8%). Half of respondents (645; weighted percentage, 45.6%) indicated that they "definitely" or "probably" will vaccinate their child aged 6 months through 4 years once they became eligible. However, only one-fifth (396; weighted percentage, 19.0%) indicated they would get a COVID-19 vaccine for their child in this age group within 3 months of them becoming eligible for vaccination. Vaccine safety and efficacy were parents' top concerns, and receiving more information about safety and efficacy were the top facilitators to COVID-19 vaccination for this age group. A doctor's office or clinic and local pharmacy were the most trusted COVID-19 vaccination locations for this age group. Conclusions and Relevance: These results suggest that only a minority of parents of children in this age group are eager to vaccinate their children within the first few months of eligibility, with widespread concerns about COVID-19 vaccination for this age group. Thus, considerable efforts to increase parental COVID-19 vaccine confidence for children aged 6 months through 4 years may be needed to maximize COVID-19 vaccination for this age group in the United States.

Indexed as

COVID-19COVID-19 VaccinesAdultChildCross-Sectional StudiesHumansIntentionMaleParentsUnited StatesVaccinationYoung AdultCOVID-19 Vaccines

Identifiers

PMID35921107
PMCPMC9350710
OpenAlexW4289593688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.